Brief: IX Biopharma Obtains Approval And Registration Of Wafesil In Australia
19/06/2018 10:31
June 19 (Reuters) - IX Biopharma Ltd IXBI.SI :
* OBTAINS APPROVAL AND REGISTRATION OF WAFESIL FOR TREATMENT
OF
MALE ERECTILE DYSFUNCTION IN AUSTRALIA
Source text for Eikon: ID:nSN1XLyz6
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture